Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial
PaperCitations, authors & open-access status
Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 582 citations, 2017 year and green oa status.
582
Citations
2017
Year
green
OA Status